Ignite Creation Date:
2025-12-24 @ 1:10 PM
Ignite Modification Date:
2025-12-27 @ 9:28 PM
Study NCT ID:
NCT03240861
Status:
TERMINATED
Last Update Posted:
2023-11-01
First Post:
2017-06-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-26
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-22
First Submit QC Date:
None
Study First Post Date:
2017-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-30
Last Update Post Date:
2023-11-01
Last Update Post Date Type:
ACTUAL